Ahn-Gook Pharmaceutical Co., Ltd. (KOSDAQ:001540)
South Korea · Delayed Price · Currency is KRW 7,940.00
+70.00 (0.89%)
Last updated: Sep 17, 2025, 9:00 AM KST
Ahn-Gook Pharmaceutical Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Net Income | 6,103 | 16,845 | 1,290 | 6,875 | 3,939 | -1,315 | Upgrade |
Depreciation & Amortization | 8,995 | 7,698 | 5,023 | 4,930 | 4,507 | 4,683 | Upgrade |
Loss (Gain) From Sale of Assets | 259.58 | -13,216 | -17.13 | -28.25 | -138.65 | 60.42 | Upgrade |
Asset Writedown & Restructuring Costs | 219.98 | 219.98 | - | 37.78 | - | - | Upgrade |
Loss (Gain) From Sale of Investments | -361.04 | -229.34 | -920.69 | 889.36 | -2,033 | -625.7 | Upgrade |
Loss (Gain) on Equity Investments | 2,389 | -1,352 | 1,641 | 1,645 | -2,613 | -1,780 | Upgrade |
Provision & Write-off of Bad Debts | -179.94 | -83.27 | 757.97 | 129.7 | 171.68 | 1,025 | Upgrade |
Other Operating Activities | 1,462 | 8,165 | 4,747 | 5,478 | 8,724 | 5,462 | Upgrade |
Change in Accounts Receivable | 23,547 | 3,541 | -7,972 | -11,980 | -10,171 | 8,940 | Upgrade |
Change in Inventory | -4,865 | -10,008 | -12,861 | -4,497 | -3,969 | -1,260 | Upgrade |
Change in Accounts Payable | -2,701 | -4,931 | 2,569 | 2,528 | 1,090 | -1,506 | Upgrade |
Change in Other Net Operating Assets | 3,128 | -1,735 | 4,415 | -4,219 | 1,964 | -2,493 | Upgrade |
Operating Cash Flow | 37,997 | 4,914 | -1,328 | 1,788 | 1,472 | 11,190 | Upgrade |
Operating Cash Flow Growth | - | - | - | 21.49% | -86.84% | -49.32% | Upgrade |
Capital Expenditures | -8,054 | -75,887 | -5,474 | -2,931 | -4,035 | -24,119 | Upgrade |
Sale of Property, Plant & Equipment | 832.66 | 11,833 | 11,201 | 15.5 | 42.09 | 26.98 | Upgrade |
Sale (Purchase) of Intangibles | -241.48 | -395.05 | -708.77 | -735.39 | -1,028 | -354.78 | Upgrade |
Investment in Securities | -3,383 | -10,938 | 12,167 | 9,960 | 4,931 | 15,021 | Upgrade |
Other Investing Activities | - | 0 | 0 | -0 | 62.75 | - | Upgrade |
Investing Cash Flow | -10,846 | -75,386 | 17,186 | 6,431 | 3,118 | -9,426 | Upgrade |
Long-Term Debt Issued | - | 60,000 | 10,000 | - | - | 2,500 | Upgrade |
Long-Term Debt Repaid | - | -301.93 | -12,593 | -662.99 | -889.69 | -11,439 | Upgrade |
Net Debt Issued (Repaid) | -223.94 | 59,698 | -2,593 | -662.99 | -889.69 | -8,939 | Upgrade |
Repurchase of Common Stock | - | - | - | -554 | -435.14 | - | Upgrade |
Dividends Paid | -5,001 | -2,500 | -2,500 | -2,511 | -2,521 | -2,521 | Upgrade |
Other Financing Activities | -0 | -0 | - | - | - | - | Upgrade |
Financing Cash Flow | -5,225 | 57,198 | -5,093 | -3,728 | -3,846 | -11,460 | Upgrade |
Foreign Exchange Rate Adjustments | -46.54 | 127.64 | 8.08 | 77.69 | 136.61 | -281.98 | Upgrade |
Net Cash Flow | 21,880 | -13,147 | 10,772 | 4,569 | 881.42 | -9,978 | Upgrade |
Free Cash Flow | 29,943 | -70,972 | -6,802 | -1,143 | -2,563 | -12,929 | Upgrade |
Free Cash Flow Margin | 10.30% | -26.18% | -2.91% | -0.56% | -1.57% | -9.02% | Upgrade |
Free Cash Flow Per Share | 2634.58 | -6244.63 | -598.47 | -100.42 | -223.77 | -1022.23 | Upgrade |
Cash Interest Paid | 3,119 | 2,665 | 976.99 | 662.47 | 121.11 | 414.62 | Upgrade |
Cash Income Tax Paid | 4,077 | 652.73 | 2,921 | 713.85 | 101.29 | 3,301 | Upgrade |
Levered Free Cash Flow | 27,485 | -82,472 | 4,491 | 1,732 | -988.07 | -12,257 | Upgrade |
Unlevered Free Cash Flow | 29,416 | -80,595 | 4,581 | 1,832 | -915.05 | -11,784 | Upgrade |
Change in Working Capital | 19,109 | -13,134 | -13,849 | -18,168 | -11,086 | 3,681 | Upgrade |
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.